Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
ct largest » _ largest (Expand Search)
ic cases » 19 cases (Expand Search), _ cases (Expand Search), 3 cases (Expand Search)
c larger » _ larger (Expand Search), c large (Expand Search), _ large (Expand Search)
1 cases » 19 cases (Expand Search), 16 cases (Expand Search), _ cases (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
ct largest » _ largest (Expand Search)
ic cases » 19 cases (Expand Search), _ cases (Expand Search), 3 cases (Expand Search)
c larger » _ larger (Expand Search), c large (Expand Search), _ large (Expand Search)
1 cases » 19 cases (Expand Search), 16 cases (Expand Search), _ cases (Expand Search)
-
161
-
162
-
163
Estimated seroconversion profiles from the projection scenarios on increased MCV1 and MCV2 coverage.
Published 2025Subjects: -
164
-
165
-
166
-
167
Spectroscopic characterization of wild-type and p.R163C αB-crystallin: CD, FTIR and Raman analysis.
Published 2025Subjects: -
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
Prevalence of TAA increases with <i>FBN1</i> variant rs1561207 status and bradycardia.
Published 2021“…<p><b>(A)</b> Increase in TAA prevalence per 100,000 participants in the UK Biobank is noted in the homozygotes for the minor allele (T/T) in comparison to the heterozygotes (C/T) and the noncarriers (C/C) in a pronounced stepwise, “dosage-dependent” manner (P-value = 1.57x10<sup>-6</sup>, OR per T allele 1.615). …”
-
176
-
177
-
178
-
179
-
180